RECOMBINANT HUMAN THYROTROPIN VERSUS THYROID HORMONE WITHDRAWAL IN DIFFERENTIATED THYROID CARCINOMA FOLLOW-UP: A SINGLE CENTER EXPERIENCE

ŞAHİN M., AYDOĞAN B., ÖZKAN E., EMRAL R., GÜLLÜ S., ERDOĞAN M. F., ...Daha Fazla

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.17, sa.3, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4183/aeb.2021.337
  • Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Anahtar Kelimeler: differentiated thyroid cancer, thyroid hormone withdrawal, recombinant human thyroid-stimulating hormone, whole body scan, stimulated thyroglobulin, WHOLE-BODY SCINTIGRAPHY, LOW-RISK PATIENTS, SERUM THYROGLOBULIN, HUMAN TSH, RADIOIODINE SCINTIGRAPHY, ASSOCIATION GUIDELINES, POSITIVE PATIENTS, STIMULATED SERUM, DIAGNOSTIC-VALUE, CANCER PATIENTS
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction. Our goal was to evaluate and compare the diagnostic utility of thyroid hormone withdrawal (THW) and recombinant thyroid-stimulating hormone (rhTSH) methods in detecting recurrence/persistence (R/PD) of differentiated thyroid carcinoma (DTC).